ATRIUM HEALTH NAVICENT PEACH

45 CFR § 180 compliance

F · 55

This hospital published little of what § 180 requires.

●Machine-readable file published

○Gross / standard charges

○Discounted cash price

●Payer-specific negotiated rates

○Min / max negotiated charges

●Free, public, no login required

Procedures listed

14,988

Insurances with rates

CPT / HCPCS codes

13,335

Source MRF

csv ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J2326	NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION	$1,482,459	$741,229	—	—	1
J0801	CORTICOTROPIN 80 UNIT/ML INJECTION GEL	$464,366	$232,183	—	—	0
C9293	GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION	$442,646	$221,323	—	—	0
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$328,506	$164,253	—	—	1
J9269	TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION	$312,299	$156,150	—	—	1
J9348	NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION	$280,233	$140,117	—	—	1
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$221,915	$110,958	—	—	1
J9274	TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION	$189,490	$94,745	—	—	1
J1303	RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION	$185,645	$92,822	—	—	2
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN	$172,951	$86,475	—	—	1
J9266	PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION	$172,113	$86,056	—	—	1
J0202	ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION	$163,202	$81,601	—	—	1
J1304	TOFERSEN 100 MG/15 ML (6.7 MG/ML) INTRATHECAL SOLUTION	$153,737	$76,869	—	—	1
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE	$151,989	$75,994	—	—	1
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$139,906	$69,953	—	—	1
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$132,868	$66,434	—	—	2
J1305	EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION	$130,395	$65,198	—	—	2
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$119,458	$59,729	—	—	1
J9382	ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION	$109,894	$54,947	—	—	3
J2840	SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION	$109,783	$54,891	—	—	1
J2427	PALIPERIDONE PALMITATE (3 MONTH) 819 MG/2.63 ML INTRAMUSCULAR SYRINGE	$109,419	$54,709	—	—	1
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$109,148	$54,574	—	—	1
J9307	PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION	$108,840	$54,420	—	—	2
J0222	PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION	$105,214	$52,607	—	—	1
J0584	BUROSUMAB-TWZA 30 MG/ML SUBCUTANEOUS SOLUTION	$100,778	$50,389	—	—	2
J3263	TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION	$99,930	$49,965	—	—	1
J9119	CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION	$98,163	$49,081	—	—	1
J2323	NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION	$91,805	$45,903	—	—	1
J2997	ALTEPLASE 100 MG INTRAVENOUS SOLUTION	$91,791	$45,895	—	—	2
J1930	LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE	$87,161	$43,581	—	—	1
J9301	OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION	$79,718	$39,859	—	—	1
J9022	ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION	$72,906	$36,453	—	—	1
J9210	EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION	$71,833	$35,916	—	—	2
J9063	MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION	$71,331	$35,666	—	—	1
J1323	ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION	$69,940	$34,970	—	—	4
J9332	EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION	$66,572	$33,286	—	—	1
J9333	ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION	$65,876	$32,938	—	—	2
J9306	PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION	$63,140	$31,570	—	—	1
J1932	LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE	$62,612	$31,306	—	—	1
J1299	ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION	$60,388	$30,194	—	—	1
J0517	BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE	$55,627	$27,814	—	—	1
J2267	MIRIKIZUMAB-MRKZ 100 MG/ML SUBCUTANEOUS PEN INJECTOR	$54,058	$27,029	—	—	2
J9271	PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION	$53,534	$26,767	—	—	3
J9038	AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION	$50,819	$25,409	—	—	2
J2506	PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR	$48,332	$24,166	—	—	1
J3315	TRIPTORELIN PAMOATE 22.5 MG IM SUSPENSION	$47,704	$23,852	—	—	2
J9227	ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION	$44,427	$22,214	—	—	2
J9204	MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION	$43,420	$21,710	—	—	1
J0739	CABOTEGRAVIR ER 600 MG/3 ML (200 MG/ML) IM SUSPENSION,EXTENDED RELEASE	$43,296	$21,648	—	—	3
A9517	SODIUM IODIDE-131 (I-131) 500 MCI/0.5 ML ORAL KIT (THERAPEUTIC)	$42,188	$21,094	—	—	1

Showing top 50 of 14,988 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.